Hematologists Accepting Cigna

Daniel Deangelo, M.D.,PH.D.

Chief, Division of Leukemia Institute Physician; Professor of Medicine, Harvard Medical School

Hematology

Edward Stadtmauer, MD

Director, Hematologic Malignancies Clinical/Translational Research, Division of Hematology/Oncology; Roseman, Tarte, Harrow, and Shaffer Families' President's Distinguished Professor

Hematology

Eric Jacobsen, MD

Associate Professor of Medicine, Harvard Medical School; Clinical Director, Adult Lymphoma Program; Director, Histiocyte Disorders Center

Hematology

Paul Richardson, MD

Director in 2001, and led the study and development of several pivotal novel drugs including thalidomide, lenalidomide, bortezomib, pomalidomide, panobinostat; Professor of Medicine at Harvard Medical School in 2012, and then became Clinical Program Leader and Director of Clinical Research in 2014.

Hematology

James Foran, MD

Hematology

Jaroslaw Maciejewski, MD

Professor of Medicine

Hematology

Leo Gordon, MD

Professor, Feinberg School of Medicine

Hematology

John Glaspy, MD

Professor of Medicine

Hematology

Stephen Schuster, MD

Robert and Margarita Louis-Dreyfus Professor in Chronic Lymphocytic Leukemia and Lymphoma Clinical Care and Research; Director, Lymphoma Translational Research, Abramson Cancer Center; Associate Professor, Medicine

Hematology

Jane Winter, MD

Professor, Feinberg School of Medicine, Division of Hematology Oncology

Hematology

Nancy Lin, MD

Professor of Medicine at Harvard Medical School, Dr. Lin’s research focuses on developing more effective therapies for patients with metastatic breast ca

Hematology

Ralph Boccia, M.D.

Clinical Associate Professor of Medicine, Georgetown University; Chief Medical Officer, International Oncology Network

Hematology

George Fisher, MD

Associate Professor, Medicine, Stanford University School of Medicine

Hematology

David Henry, MD

Vice Chair, Department of Medicine; Clinical Professor of Medicine (Hematology-Oncology)

Hematology

Paolo Caimi, M.D.

Associate Professor of Medicine, Cleveland Clinic Lerner College of Medicine; Associate Director for Cell Therapy, Cleveland Clinic Taussig Cancer Center

Hematology

Jorge Castillo, MD

Associate Professor at Harvard Medical School, an Institute Physician at the Dana-Farber Cancer Institute, and the Clinical Director of the Bing Center for Waldenström M; Director of the WM-NET, a consortium composed of academic researchers in the United States focused on designing and executing clinical research in patients wi

Hematology

Sunita Nasta, MD

Section Chief, Lymphoma, Hematology-Oncology; Professor of Clinical Medicine (Hematology-Oncology); Chair, Clinical Trials Review Monitoring Committee; Committee Chair, Penn Institutional Review Board

Hematology

Thomas Kupper, MD

Thomas B. Fitzpatrick Professor of Dermatology; Chair, Department of Dermatology, Brigham and Women's Hospital

Hematology

Michael Morse, M.D.

Professor of Medicine, Duke University School of Medicine

Hematology

Alan Saven, M.D.

Director, Scripps Cancer Center; Head, Division of Hematology and Oncology

Hematology